4894

Cuorips Inc.

クオリプス株式会社
Healthcare · Biotechnology
Cuorips Inc. engages in the research, development, manufacture, commercialization, and sale of human iPS cell-derived cardiomyocyte sheets. The company offers cellular and tissue-based, and cell processing products. It also provides contract development and manufacturing, and consulting services. The company was formerly known as Cuore Inc. and changed its name to Cuorips Inc. in June 2017. Cuorips Inc. was incorporated in 2017 and is headquartered in Tokyo, Japan.
← Companies
Price
¥4,955
Market Cap
¥40.1B
Ent. Value
—
Net Cash est
—
Shares Out.
8.1M
P / E
—
EV / EBIT
—
P / Book
7.27×
P / NCAV
8.16×
Div. Yield
—
Financials
Metric FY 2024
EDINET ↗ 		FY 2023
EDINET ↗ 		FY 2022
EDINET ↗
Net Sales ¥175M ¥23M ¥38M
Cost of Sales ¥7M ¥13M ¥17M
Gross Profit ¥168M ¥10M ¥21M
SG&A ¥759M ¥598M ¥471M
Operating Income ¥-590M ¥-588M ¥-450M
Non-Operating Income ¥7M ¥1M ¥0M
Interest Income ¥4M ¥0M ¥0M
Non-Operating Expenses ¥59M ¥41M ¥0M
Ordinary Income ¥-642M ¥-628M ¥-450M
Pre-tax Income ¥-642M ¥-630M ¥-450M
Income Taxes ¥3M ¥2M ¥2M
Current Tax ¥4M ¥4M ¥3M
Deferred Tax ¥-0M ¥-1M ¥-1M
Net Income (owners) ¥-644M ¥-632M ¥-452M
Minority Interest ¥-1M ¥0M —
Comprehensive Income ¥-601M ¥-632M —
EBITDA ¥-514M ¥-518M ¥-372M
EPS ¥-80.52 ¥-85.86 ¥-79.90
Shares Outstanding 8.1M 8.0M 5.7M
Shares Issued (total) 8.1M 8.0M 5.7M
Treasury Shares 0.0M 0.0M —